시장보고서
상품코드
1293844

티슈 엔지니어링(조직공학) 시장 : 성장, 미래 전망, 경쟁 분석(2023-2031년)

Tissue Engineering Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

발행일: | 리서치사: Acute Market Reports | 페이지 정보: 영문 116 Pages | 배송안내 : 1-2일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

티슈 엔지니어링(조직공학) 시장은 2031년까지 14% 성장할 것으로 예상됩니다. 티슈 엔지니어링은 세포와 콜라겐의 스캐폴드에서 새로운 결합조직이나 장기를 성장시켜 완전한 기능을 가진 장기를 만들어 기증자 숙주에게 되돌려주는 연구입니다. 이 기술을 통해 장기는 이식 후 성장하여 면역학적 거부반응을 일으키지 않습니다. 티슈 엔지니어링은 주로 화상 및 사고 창상 치료, 미용 성형, 선천성 기형 교정, 창상 치료, 정형외과, 신경학 등에 사용됩니다. 세포 배양 기술의 발전은 티슈 엔지니어링의 의료 응용에 대한 적응을 촉진하고 있습니다. 또한 동물 실험 모델의 사용은 다양한 윤리적 문제를 야기하고 있으므로 티슈 엔지니어링적으로 제조된 인간 동등물에 대한 수요가 빠르게 증가하고 있습니다.

티슈 엔지니어링 시장은 장기 부족 문제를 피할 수 있으므로 급속한 다각화와 성장으로 인해 급속한 성장이 예상됩니다. 또한 생화학, 생체재료, 분자 의학, 유전학, 나노기술, 바이오메디컬 엔지니어링의 발전은 2016-2022년의 예측 기간 중 시장을 더욱 지원할 것으로 보입니다. 시장 전문가들에 따르면 신경학 및 치과 분야에서 티슈 엔지니어링의 응용이 증가함에 따라 티슈 엔지니어링 시장의 향후 성장이 예상됩니다. 또한 티슈 엔지니어링과 관련된 정부의 우호적인 정책도 이 시장을 개척할 수 있는 기회를 증가시킬 것입니다.

목차

제1장 서문

  • 리포트 내용
    • 보고서의 목적
    • 대상 독자
    • 주요 제공 상품
  • 시장 세분화
  • 조사 방법

제2장 주요 요약

제3장 티슈 엔지니어링 시장 : 경쟁 분석

  • 주요 벤더의 시장 포지셔닝
  • 벤더가 채택하는 전략
  • 주요 산업 전략
  • Tier 분석 : 2022 vs 2031

제4장 티슈 엔지니어링 시장 : 거시적 분석과 시장 역학

  • 서론
  • 세계의 티슈 엔지니어링 시장 금액 2021-2031
  • 시장 역학
    • 시장 촉진요인
    • 시장 억제요인
    • 주요 과제
    • 주요 기회
  • 촉진요인과 억제요인의 영향 분석
  • 시소 분석

제5장 티슈 엔지니어링 시장 : 유형별 2021-2031

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 합성 스캐폴드 재료
      • 합성 폴리머
      • 기타
    • 바이오로지컬 스캐폴드 재료
      • 콜라겐
      • 기타
    • 기타

제6장 티슈 엔지니어링 시장 : 용도별 2021-2031

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 정형외과·근골격계
    • 신경학
    • 심혈관
    • 피부·외피
    • 치과
    • 기타

제7장 북미의 티슈 엔지니어링 시장 2021-2031

  • 시장 개요
  • 티슈 엔지니어링 시장 : 유형별 2021-2031
  • 티슈 엔지니어링 시장 : 용도별 2021-2031
  • 티슈 엔지니어링 시장 : 지역별 2021-2031
    • 북미
      • 미국
      • 캐나다
      • 기타 북미 지역

제8장 영국·유럽연합의 티슈 엔지니어링 시장 2021-2031

  • 시장 개요
  • 티슈 엔지니어링 시장 : 유형별 2021-2031
  • 티슈 엔지니어링 시장 : 용도별 2021-2031
  • 티슈 엔지니어링 시장 : 지역별 2021-2031
    • 영국·유럽연합
      • 영국
      • 독일
      • 스페인
      • 이탈리아
      • 프랑스
      • 기타 유럽 지역

제9장 아시아태평양의 티슈 엔지니어링 시장 2021-2031

  • 시장 개요
  • 티슈 엔지니어링 시장 : 유형별 2021-2031
  • 티슈 엔지니어링 시장 : 용도별 2021-2031
  • 티슈 엔지니어링 시장 : 지역별 2021-2031
    • 아시아태평양
      • 중국
      • 일본
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양

제10장 라틴아메리카의 티슈 엔지니어링 시장 2021-2031

  • 시장 개요
  • 티슈 엔지니어링 시장 : 유형별 2021-2031
  • 티슈 엔지니어링 시장 : 용도별 2021-2031
  • 티슈 엔지니어링 시장 : 지역별 2021-2031
    • 라틴아메리카
      • 브라질
      • 멕시코
      • 기타 라틴아메리카 지역

제11장 중동 및 아프리카의 티슈 엔지니어링 시장 2021-2031

  • 시장 개요
  • 티슈 엔지니어링 시장 : 유형별 2021-2031
  • 티슈 엔지니어링 시장 : 용도별 2021-2031
  • 티슈 엔지니어링 시장 : 지역별 2021-2031
    • 중동 및 아프리카
      • GCC
      • 아프리카
      • 기타 중동 및 아프리카

제12장 기업 개요

  • ABBVIE INC.(ALLERGEN PLC.)
  • B. BRAUN MELSUNGEN AG
  • BECTON
  • DICKINSON AND COMPANY(C. R. BARD INC.)
  • INTEGRA LIFESCIENCES
  • ORGANOGENESIS HOLDINGS
  • SID MARTIN BIOTECH(AXOGEN)
  • SMITH & NEPHEW PLC.(OSIRIS THERAPEUTICS)
  • TISSUETECH INC.
  • VERICEL CORPORATION
  • ZIMMER BIOMET HOLDINGS INC.
KSA 23.07.04

Tissue Engineering Market is Expected to Grow at 14% by 2031. Tissue Engineering is the study of the growth of new connective tissues, or organs, from cells and a collagenous scaffold to produce a fully functional organ for implantation back into the donor host. This technique allows the organs to be grown from implantation and hence is free from immunological rejection. Tissue engineering is primarily used for the treatment of burns and accident wounds, cosmetic surgeries, correcting birth defects, wound care, orthopedics, and neurology, amongst others. Advancements in cell culture technology have encouraged the adaptation of tissue engineering in healthcare applications. Moreover, the use of animal testing models has raised various ethical issues and hence, the demand for tissue-engineered human equivalents is growing at a rapid rate.

Tissue engineering market is expected to witness rapid growth due to the rapid diversification and growth as it allows circumvention of the problem of organ shortage. Furthermore, the development in biochemistry, biomaterials, molecular medicine, genetics, nanotechnology, and biomedical engineering would further assist the market during the forecast period of 2016-2022. According to market experts, the increasing applications of tissue engineering in neurological and dental segments would add up to the growth of the tissue engineering market in the future. Favorable policies of the governments in relation to tissue engineering will also add incremental opportunities to exploit this market.

The global Tissue Engineering Market is segmented on the following bases:

Key Players Identified for Tissue Engineering Market Include:

ABBVIE INC. (ALLERGEN PLC.), B. BRAUN MELSUNGEN AG, BECTON, DICKINSON, AND COMPANY (C. R. BARD, INC.), INTEGRA LIFESCIENCES, ORGANOGENESIS HOLDINGS, SID MARTIN BIOTECH (AXOGEN), SMITH & NEPHEW PLC. (OSIRIS THERAPEUTICS), TISSUETECH INC., VERICEL CORPORATION, ZIMMER BIOMET HOLDINGS, INC.

Historical & Forecast Period

This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Tissue Engineering market is as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price, and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Tissue Engineering market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approaches for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Segmentation

Type

  • Synthetic Scaffold Material
    • Synthetic Polymer
    • Others
  • Biologically Derived Scaffold Material
    • Collagen
    • Others
    • Others

Application

  • Orthopedics and Musculoskeletal
  • Neurology
  • Cardiovascular
  • Skin and Integumentary
  • Dental
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Tissue Engineering market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Tissue Engineering market?
  • Which is the largest regional market for Tissue Engineering market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Tissue Engineering market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Tissue Engineering market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Tissue Engineering Market
  • 2.2. Global Tissue Engineering Market, By Type, 2022 (US$ Million)
  • 2.3. Global Tissue Engineering Market, By Application, 2022 (US$ Million)
  • 2.4. Global Tissue Engineering Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Tissue Engineering Market: Competitive Analysis

  • 3.1. Market Positioning of Key Tissue Engineering Market Vendors
  • 3.2. Strategies Adopted by Tissue Engineering Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Tissue Engineering Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Tissue Engineering Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Tissue Engineering Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Synthetic Scaffold Material
      • 5.3.1.1. Synthetic Polymer
      • 5.3.1.2. Others
    • 5.3.2. Biologically Derived Scaffold Material
      • 5.3.2.1. Collagen
      • 5.3.2.2. Others
    • 5.3.3. Others

6. Tissue Engineering Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Orthopedics and Musculoskeletal
    • 6.3.2. Neurology
    • 6.3.3. Cardiovascular
    • 6.3.4. Skin and Integumentary
    • 6.3.5. Dental
    • 6.3.6. Others

7. North America Tissue Engineering Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
  • 7.3. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
  • 7.4.Tissue Engineering Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.1.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.2.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.3.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)

8. UK and European Union Tissue Engineering Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
  • 8.3. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
  • 8.4.Tissue Engineering Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.1.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.2.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.3.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.4.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.5.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.6.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)

9. Asia Pacific Tissue Engineering Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
  • 9.3. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
  • 9.4.Tissue Engineering Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.1.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.2.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.3.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.4.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.5.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.6.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)

10. Latin America Tissue Engineering Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
  • 10.3. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
  • 10.4.Tissue Engineering Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.1.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.2.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.3.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)

11. Middle East and Africa Tissue Engineering Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
  • 11.3. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
  • 11.4.Tissue Engineering Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.1.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.2.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Tissue Engineering Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.3.1. Tissue Engineering Market: By Application, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. ABBVIE INC. (ALLERGEN PLC.)
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. B. BRAUN MELSUNGEN AG
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. BECTON
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. DICKINSON AND COMPANY (C. R. BARD, INC.)
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. INTEGRA LIFESCIENCES
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. ORGANOGENESIS HOLDINGS
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. SID MARTIN BIOTECH (AXOGEN)
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. SMITH & NEPHEW PLC. (OSIRIS THERAPEUTICS)
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. TISSUETECH INC.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. VERICEL CORPORATION
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. ZIMMER BIOMET HOLDINGS, INC.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제